Wednesday, 18 Sep 2019

You are here

The RheumNow Week in Review – 9 September 2016

Dr. Jack Cush reviews highlight in news and journal reports from this week on RheumNow.com

  1. Inflammatory bowel disease patients Rx with TNF inhibitors have no higher risk of renal cell carcinoma; OR 0.8 (0.3-2.5) men & 1.4 (0.2-5.5) women. http://buff.ly/2cah6WO
  2. Fracture nonunion (~5%) risk increased by RA, OA, diabetes, NSAIDs, opioids, anticoagulants, and anticonvulsants. https://t.co/XA7EV31Qh9
  3. In new onset PMR, women report worse general and PMR-specific health problems than men; HAQ, fatigue, sleep, anxiety, depression, etc. https://t.co/WYW7QgG9QP
  4. Frequency of IgA Vasculitis in kids has significantly declined between 2003-2012. G I & renal Sxs associated with longer hospital stays. https://t.co/PH3IB1MZNK
  5. Dalbeth cautions about Rx asymptomatic hyperuricemia with urate lowering therapy; such patients may be at higher risk of allopurinol toxicity https://t.co/pWcP6wI7ea
  6. Subset of primary Sjogrens patients (27%) have anti-CarP Abs that correlate with RF & greater severity (higher focus score) https://t.co/My4vzCWO3d
  7. EU grants approval for Orencia (abatacept; IV or SC) for MTX naive (early) RA patients with moderate-severe disease https://t.co/gcGbESdxCp
  8. 63% of RA patients have some MTX toxicity; 22% its moderate-severe. Giving Caffeine at time of MTX (coffee, Dark chocolate) showed 55% improvedment! https://t.co/YegVkoODoF
  9. TNFi induced sardoidosis; 90 cases of sarcoidosis ascribed to TNF inhibitor Rx reviewed, most with Enbrel; 71 resolved with discontinuation. https://t.co/cBxP4KX9L7
  10. 30% of Biologics us is monotherapy. Choy et al reviews comparative success, reasons, pitfalls of biologic monotherapy https://t.co/UAtLKQbxx7
  11. P. Gingivalis Antibodies Antedate Rheumatoid Arthritis Onset. 
  12. Shingles Plus Autoimmune Disease Hikes Stroke Risk by 36-76%
  13. Karolinska Scandal May Undermine the Nobel Prize. 
  14. Is Biologic Safety Different in the Elderly? 
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

RheumNow Podcast – The End of Arthritis (9.13.19)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

RheumNow Podcast – Do’s and Don’ts in Spondylitis (9.5.19)

Dr. Jack Cush reviews the news and important research published in the last two weeks on RheumNow.com.

Influenza Vaccination Update

FDA's Vaccines and Related Biological Products Advisory Committee met in Silver Spring, Maryland, on March 6 and 22, 2019, to select the influenza viruses for the composition of the influenza vaccine for the 2019-2020 U.S. influenza season.

RheumNow Podcast - I Wanna New Drug (8-30-19)

Dr. Jack Cush vents on choosing new therapies in rheumatoid arthritis.

RheumNow Podcast – Upadacitinib FDA Approved for RA (8.23.19)

Dr. Jack Cush reports on the news and journal reports from the past week on RheumNow.com, including: how your genetics may shape your microbiome; GERD as a risk factor for TMJ?; how can MDA-5+ dermatomyositis be any worse; new drug happenings; StillsNow.com; and more.